Health & Medicine
India's Regulatory Authorities Crack Down on Unregulated GLP-1 Drug Use
The Drug Controller General of India is ramping up efforts to curb unauthorized sales of GLP-1 diabetes medications. Recent inspections have revealed significant regulatory violations across the…